山河智能(002097.SZ):擬斥4000萬元新設山河廣州公司 為華南智能裝備產業園運營主體
格隆匯1月20日丨山河智能(002097.SZ)宣佈,公司擬使用自有資金人民幣4000萬元在廣東省廣州市投資設立山河智能(廣州)工程裝備有限公司(具體以工商行政主管部門核准的名稱為準;簡稱“山河廣州”)。
設立山河廣州是公司落實“一體兩翼”區位戰略的重要舉措,山河廣州設立後作為華南智能裝備產業園的運營主體,將建成以研製地下空間開發智能化成套裝備為主,包含工程機械再製造、工法研究、工程設計施工、市場保障中心為輔的綜合性基地。
以此為平台,公司將發揮自身的技術優勢、機制優勢、主場優勢,結合國資系統的生產要素資源和社會化市場資源,深耕粵港澳大灣區市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.